EDUARDO
DÍAZ-RUBIO GARCÍA
Investigador hasta 2020
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (6)
2019
-
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
Critical Reviews in Oncology/Hematology, Vol. 134, pp. 39-45
2014
-
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants
International Journal of Cancer, Vol. 134, Núm. 9, pp. 2088-2097
-
Capillary Electrophoresis Analysis of Conventional Splicing Assays: IARC Analytical and Clinical Classification of 31 BRCA2 Genetic Variants
Human Mutation, Vol. 35, Núm. 1, pp. 53-57
-
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data
The Lancet Oncology, Vol. 15, Núm. 4, pp. 406-414
-
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: A report from the ENIGMA consortium
Human Molecular Genetics, Vol. 23, Núm. 14, pp. 3666-3680
2012
-
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: Review of the literature, and reevaluation of the genetic mechanisms involved in their origin
Breast Cancer Research and Treatment, Vol. 133, Núm. 1, pp. 273-283